Rang	Name	Position
1	Mr. Derek J. Maetzold	Founder, CEO, President & Director
2	Mr. Frank Stokes	CFO & Treasurer
3	Ms. Kristen M. Oelschlager R.N.	Chief Operating Officer
4	Mr. Tobin W. Juvenal	Chief Commercial Officer
5	Ms. Camilla Zuckero	Vice President of Investor Relations & Corporate Affairs
6	Mr. Kevin Doman	Vice President of Sales
7	Dr. Jay Braxton Pharm.D.	VP of Marketing & Brand Manager of Uveal Melanoma (UM)
8	Ms. Keli Greenberg	Vice President of Human Resources
9	Dr. Matthew Goldberg M.D.	Senior Vice President of Medical
10	Ms. Trisha Poteet	Senior VP of Clinical Services & Manufacturing Operations

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	9,76%	96,44 Mio. USD
2	RTW INVESTMENTS, LLC	9,03%	89,18 Mio. USD
3	Principal Financial Group Inc	5,65%	55,82 Mio. USD
4	Portolan Capital Management, LLC	4,42%	43,66 Mio. USD
5	Vanguard Capital Management, LLC	3,85%	38,07 Mio. USD
6	Summit Partners Public Asset Management, LLC	3,08%	30,41 Mio. USD
7	Allianz Asset Management AG	2,88%	28,43 Mio. USD
8	Vanguard Portfolio Management, LLC	2,82%	27,86 Mio. USD
9	Dimensional Fund Advisors, Inc.	2,59%	25,58 Mio. USD
10	State Street Corp	2,52%	24,86 Mio. USD
11	Geode Capital Management, LLC	2,38%	23,54 Mio. USD
12	Qube Research & Technologies	1,83%	18,09 Mio. USD
13	AIGH Capital Management, LLC	1,78%	17,62 Mio. USD
14	Palisade Capital Management LLc	1,75%	17,33 Mio. USD
15	Renaissance Technologies Corp	1,74%	17,23 Mio. USD
16	Nuveen, LLC	1,71%	16,88 Mio. USD
17	Acadian Asset Management LLC	1,59%	15,66 Mio. USD
18	Morgan Stanley - Brokerage Accounts	1,40%	13,87 Mio. USD
19	Connor Clark & Lunn Inv Mgmt Ltd	1,23%	12,19 Mio. USD
20	Kennedy Capital Management Inc	1,14%	11,26 Mio. USD